Amgen – Amgen Inc. stock outperforms competitors despite losses on the day
Shares of Amgen Inc.
shed 0.16% to $236.82 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index
rising 0.02% to 4,227.26 and the Dow Jones Industrial Average
falling 0.09% to 34,599.82. The stock’s fall snapped a four-day winning streak. Amgen Inc. closed $39.87 below its 52-week high ($276.69), which the company reached on January 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson
fell 0.88% to $163.39, Roche Holding AG Part. Cert.
rose 1.07% to $368.90, and Pfizer Inc.
fell 0.36% to $38.85. Trading volume (1.6 M) remained 947,490 below its 50-day average volume of 2.6 M.